drugset / Trial / NCT05415462
A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The primary objectives of this study are to evaluate the humoral immunogenicity of mRNA-1010 relative to that of an active comparator against vaccine-matched influenza A and B strains at Day 29, and to evaluate the safety and reactogenicity of mRNA-1010.
Timeline
- Start
- 2022-06-06
- Primary completion
- 2023-09-04
- Completion
- 2023-09-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fluarix Tetra | Vaccine | — | Intramuscular |
| Subject | Quadrivalent influenza vaccine | Vaccine | — | Intramuscular |